Patents by Inventor Anthony G. Day

Anthony G. Day has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Microalgae-Derived Compositions For Improving The Health And Appearance Of Skin
    Publication number: 20080299147
    Abstract: Provided herein are microalgal skin care compositions and methods of improving the health and appearance of skin. Also provided are methods of using polysaccharides for applications such as topical personal care products, cosmetics, and wrinkle reduction compositions. The invention also provides novel decolorized microalgal compositions useful for improving the health and appearance of skin. The invention also includes insoluble polysaccharide particles for application to human skin.
    Type: Application
    Filed: October 31, 2007
    Publication date: December 4, 2008
    Applicant: Solazyme, Inc.
    Inventors: Harrison F. Dillon, Anwar Zaman, Anthony G. Day
  • Isolating Human Antibodies
    Publication number: 20080268420
    Abstract: The invention is drawn to a method of isolating human antibodies.
    Type: Application
    Filed: October 18, 2005
    Publication date: October 30, 2008
    Inventors: Yiyou Chen, Dan Chen, Anthony G. Day, David A. Estell, Wei Geng
  • FGF-5 Supported and Binding Peptides
    Publication number: 20080269139
    Abstract: The present invention provides peptides and supported peptides that bind to FGF-5.
    Type: Application
    Filed: February 19, 2008
    Publication date: October 30, 2008
    Inventors: Anthony G. Day, Christopher J. Murray, Scott D. Power, Beverley Rider Turnquest
  • TARGETED ENZYMES
    Publication number: 20080233100
    Abstract: The present invention provides targeted enzymes that bind to targets better than the corresponding pre-targeted enzymes bind the target under like conditions, methods of making targeted enzymes, methods of using targeted enzymes to treat diseases, and pharmaceutical compositions comprising targeted enzymes.
    Type: Application
    Filed: January 10, 2008
    Publication date: September 25, 2008
    Inventors: Yiyou Chen, Anthony G. Day, David A. Estell, Christopher J. Murray, Scott D. Power, Volker Schellenberger
  • Tgfbeta Supported and Binding Peptides
    Publication number: 20080113917
    Abstract: The present invention provides peptides and supported peptides that bind TGF? (molecules. In some particularly preferred embodiments, the TGF? binding molecules bind TGF?-1, while in other embodiments, the TGF? binding molecules bind TGF?-2.
    Type: Application
    Filed: November 6, 2004
    Publication date: May 15, 2008
    Inventors: Anthony G. Day, David A. Estell, Christopher J. Murray, Scott D. Power, Beverley R. Turnquest
  • Methods for modulating proteins not previously known as proteases
    Publication number: 20040219609
    Abstract: The present invention relates to the proteins not previously identified as proteases; the use of those peptides in screening for compounds that modulate protease activity; treating individuals in need of treatment with the compounds or proteases; and in methods for diagnosing a disease or disorder associated with a protease of the instant invention.
    Type: Application
    Filed: July 11, 2003
    Publication date: November 4, 2004
    Inventors: Anthony G. Day, David A. Estell, Eric H. Lyons, Jian Yao
  • Enzymatic bleaching of natural non-cotton cellulosic fibers
    Patent number: 6685748
    Abstract: A method is provided for bleaching a non-cotton cellulosic fiber, yarn or fabric by contacting said fiber, yarn or fabric with a hemicellulase enzyme for a time and under conditions suitable to produce a whitening of said fiber, yarn or fabric.
    Type: Grant
    Filed: April 4, 2000
    Date of Patent: February 3, 2004
    Assignee: Genencor International, Inc.
    Inventors: Anthony G. Day, Scott D. Power, Doreen Victoria, Deborah S. Winetzky
  • Variant EGIII-like cellulase compositions
    Patent number: 6579841
    Abstract: The present invention relates to novel variant EGIII or EGIII-like cellulases which have improved stability. The variant cellulases have performance sensitive residues replaced to a residue having modified stability.
    Type: Grant
    Filed: August 4, 2000
    Date of Patent: June 17, 2003
    Assignee: Genencor International, Inc.
    Inventors: Anthony G. Day, Peter Gualfetti, Colin Mitchinson, Andrew Shaw
  • Targeted enzymes
    Publication number: 20030068792
    Abstract: The present invention provides targeted enzymes that bind to targets better than the corresponding pre-targeted enzymes bind the target under like conditions, methods of making targeted enzymes, methods of using targeted enzymes to treat diseases, and pharmaceutical compositions comprising targeted enzymes.
    Type: Application
    Filed: December 13, 2001
    Publication date: April 10, 2003
    Inventors: Yiyou Chen, Anthony G. Day, David A. Estell, Christopher J. Murray, Scott D. Power, Volker Schellenberger
  • Multifunctional polypeptides
    Publication number: 20030049689
    Abstract: The present invention provides methods and compositions relating to polypeptides engineered to bind a target and have at least two functional domains.
    Type: Application
    Filed: June 12, 2002
    Publication date: March 13, 2003
    Inventors: Cynthia Edwards, Volker Schellenberger, Christopher J. Murray, Yiyou Chen, Anthony G. Day
  • Mutant .alpha.-amylase comprising modification at residues corresponding to A210, H405 and/or T412 in Bacillus licheniformis
    Patent number: 6080568
    Abstract: Novel .alpha.-amylase enzymes are disclosed in which one or more of residues corresponding to A210, H405 and T412 in Bacillus licheniformis are mutated. The disclosed .alpha.-amylase enzymes show altered or improved stability and/or activity profiles.
    Type: Grant
    Filed: August 19, 1997
    Date of Patent: June 27, 2000
    Assignee: Genencor International, Inc.
    Inventors: Anthony G. Day, Barbara A. Swanson
  • Mutant .alpha.-amylase having introduced therein a disulfide bond
    Patent number: 6008026
    Abstract: Novel .alpha.-amylase enzymes are disclosed in which one or more disulfide bonds are introduced into the enzyme via addition or substitution of a residue with a cysteine. The disclosed .alpha.-amylase enzymes show altered or improved stability and/or activity profiles.
    Type: Grant
    Filed: July 11, 1997
    Date of Patent: December 28, 1999
    Assignee: Genencor International, Inc.
    Inventor: Anthony G. Day